News

BrainsWay (Nasdaq:BWAY) today announced the FDA granted expanded clearance for its Deep Transcranial Magnetic Stimulation ...
BrainsWay Ltd. BWAY recently secured FDA clearance for an accelerated treatment protocol using its Deep Transcranial Magnetic ...
Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression ...
BrainsWay announced it received FDA clearance of an accelerated protocol for its deep transcranial magnetic stimulation (TMS) ...
The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...
Under the new policy, nearly 1 million individuals with fee-for-service Medicaid and over 4.4 million individuals with Managed Care Organizations, will now be covered for TMS services by Medicaid in ...
In today's fast-paced financial landscape, businesses need more than just traditional banking solutions to manage their cash flow, investments, and payments efficiently. Treasury management systems ...